Find and Pitch Jounalists, Get Your Story Covered

Tags: leadership pharma Research & Development research-development biotech

	Profile	Recent Articles on Subject
1	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about GSK leaving BIO, an AbbVie schizophrenia drug failing, and more - 3 days ago STAT+: Pharmalittle: We’re reading about biotech startups, Pfizer’s RSV vaccine, and more - 7 months ago STAT+: Pharmalittle: We’re reading about Biocon eyeing weight loss drugs, Sanofi layoffs, and more - 7 months ago STAT+: Pharmalittle: We’re reading about Boehringer biosimilar frustrations, FTC warnings, and more - 7 months ago STAT+: Pharmalittle: We’re reading about BIO cutting ties with WuXi, EU pharma rules, and more - 8 months ago STAT+: Pharmalittle: Bioscience job market is upside down; Sanofi and Regeneron’s blockbuster Dupixent may find bigger market - 12 months ago
2	Lizzy Lawrence STAT News Medical devices reporter at STATnews. Loves news tips. medical reportingnews	STAT+: Pharma giant GSK is quitting BIO in latest setback for the lobbying group - 6 days ago
3	Sarah Owermohle STAT News Health reporter @STATNews. Covers Biden's agenda. Washington, District of Columbia health policyjournalism	STAT+: Pharma giant GSK is quitting BIO in latest setback for the lobbying group - 6 days ago
4	John Wilkerson STAT News STAT Washington correspondent. Healthcare Journalism	STAT+: Pharma giant GSK is quitting BIO in latest setback for the lobbying group - 6 days ago
5	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	The biotech news roundup to start your week - 10 days ago The biotech news you need to read today - 17 days ago Is pharma still fearful of the Inflation Reduction Act? - 3 months ago The biotech news you missed this week - 4 months ago STAT+: More tumult at BIO amid the company’s fourth CEO in four years - 6 months ago The Senate health committee looks into its first subpoena in 40 years - 10 months ago The biotech updates you need to read today - 11 months ago The legal pathway for experimental, ultra-rare disease treatments is rocky and expensive - 11 months ago FDA chastens pet companies over antibiotics - 11 months ago The biotech news you missed from the weekend - 11 months ago Novartis is building a new radioligand plant in China - 12 months ago Johnson & Johnson bets heavy on AI-driven drug discovery - 12 months ago Today’s biotech news roundup, in under 800 words - 12 months ago A new algorithm unveils CRISPR ‘treasure trove’ - 12 months ago These are the need-to-know biotech stories from this weekend - about 1 year ago Your Monday morning biotech news roundup - about 1 year ago Why Biogen is purposefully becoming more risk averse, according to Biogen’s CEO - about 1 year ago Candor on gene therapy, Abiomed is warned, & BTK success in MS - about 1 year ago
6	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	2024 PharmaVoice 100s: Rare Disease Warriors - 16 days ago 2024 PharmaVoice 100s: Trailblazers - 29 days ago California is a life sciences leader. Joe Panetta has been one of its most vocal advocates. - about 1 month ago What 3 layoff stories reveal about pharma’s troubles - 2 months ago Pharma’s R&D gamble: picking pipeline winners in a risky field - 5 months ago Where competition is heating up in pharma - 6 months ago 3 big recent trial flops - 7 months ago The biggest questions hanging over pharma in 2024 - 10 months ago Pharma execs sound off on trends and policies they’re tracking in 2024 - 10 months ago PharmaVoice’s Crystal Ball: What’s next in drug innovation and clinical trials - 10 months ago 10 of our most read articles in 2023 - 11 months ago Does BioMarin’s CEO shuffle signal bigger changes ahead? - about 1 year ago PharmaVoice 100s: Entrepreneurs - about 1 year ago PharmaVoice 100s: Clinical trial gurus - about 1 year ago
7	STAT Staff STAT News Frontiers of health & medicine reporting. healthmedicinejournalism	The biotech updates you need to read this morning - 24 days ago
8	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Can BioNTech sustain a post-COVID mRNA pipeline? Oncology is the next hope. - 3 months ago Execs from Bayer, Kite and Orca sound off on their launch strategies for cell and gene therapies - 6 months ago 4 offbeat biotechs making a splash in the life sciences - 7 months ago How a biotech exec is leveraging Big Pharma lessons to advance tRNA - 7 months ago
9	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	A biotech’s binary bet ends badly - 5 months ago Listen: More tumult at BIO & coercive care for sickle cell patients - 6 months ago
10	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	Listen: More tumult at BIO & coercive care for sickle cell patients - 6 months ago

Journalists covering biopharma journalism